Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Palo Alto Investors LP
Form 13F · Q2 2026

Palo Alto Investors LP

CIK 1306923申报日 2026-08-1913F-HR/A 在 EDGAR 查看原始申报 ↗
$7.2亿
申报组合市值
52
持仓数量
12
Quarters on record
Top 50
持仓数量

Palo Alto Investors LP——持仓

共 52 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1PTCT Ptc Therapeutics Inc918,846−0.3%$7495万10.4%
2ACAD Acadia Pharmaceuticals Inc2.9M−0.3%$7246万10.0%
3INSM Insmed Inc413,980−0.3%$4414万6.1%
4MIRM Mirum Pharmaceuticals Inc348,808+7.3%$4083万5.6%
5ANAB Anaptysbio Inc603,489−5.4%$4074万5.6%
6BMRN Biomarin Pharmaceutical Inc682,777−0.4%$3907万5.4%
7DYN Dyne Therapeutics Inc1.6M−0.3%$3659万5.1%
8UTHR United Therapeutics Corp Del62,587−0.4%$3391万4.7%
9IRON Disc Medicine Inc416,646+3.7%$3047万4.2%
10BIIB Biogen Inc140,279−0.3%$3031万4.2%
11IOVA Iovance Biotherapeutics Inc5.3M−16.6%$2203万3.0%
12RARE Ultragenyx Pharmaceutical In596,495+0.0%$1992万2.8%
13NVCR Novocure Ltd1.3M+0.0%$1940万2.7%
14SNDX Syndax Pharmaceuticals Inc864,986+0.0%$1891万2.6%
15ANNX Annexon Inc2.9M+0.0%$1683万2.3%
16BCAX Bicara Therapeutics Inc550,408+0.0%$1634万2.3%
17CDNA Caredx Inc531,870+0.0%$1516万2.1%
18CLDX Celldex Therapeutics Inc New399,856+34.9%$1488万2.1%
19CMPX Compass Therapeutics Inc5.8M+285.1%$1277万1.8%
20ALKS Alkermes Plc242,560+0.0%$1271万1.8%
21TRAX First Tracks Biotherapeutics603,489—$1214万1.7%
22PRTA Prothena Corp Plc1.1M−5.4%$1119万1.5%
23TVTX Travere Therapeutics Inc167,525−27.3%$952万1.3%
24TSHA Taysha Gene Therapies Inc1.4M+0.0%$948万1.3%
25ACRS Aclaris Therapeutics Inc1.6M+0.0%$854万1.2%
26AGIO Agios Pharmaceuticals Inc213,601+0.0%$793万1.1%
27CAPR Capricor Therapeutics Inc229,763+0.0%$553万0.8%
28ALGN Align Technology Inc31,389−24.4%$529万0.7%
29ORKA Oruka Therapeutics Inc33,546−44.1%$319万0.4%
30XENE Xenon Pharmaceuticals Inc51,345+0.0%$310万0.4%
31NBIX Neurocrine Biosciences Inc18,117+0.0%$305万0.4%
32EW Edwards Lifesciences Corp33,640+0.0%$304万0.4%
33STOK Stoke Therapeutics Inc84,631+0.0%$277万0.4%
34CYTK Cytokinetics Inc32,195+0.0%$274万0.4%
35PYXS Pyxis Oncology Inc864,277−14.5%$260万0.4%
36EHTH Ehealth Inc1.5M+0.0%$221万0.3%
37CRSP Crispr Therapeutics Ag39,605+0.0%$216万0.3%
38SGMT Sagimet Biosciences Inc250,000—$193万0.3%
39NUVB Nuvation Bio Inc326,609−35.8%$186万0.3%
40BNTX Biontech Se19,614+0.0%$183万0.3%
41CMPS Compass Pathways Plc115,616+0.0%$164万0.2%
42HUM Humana Inc3,985+0.0%$158万0.2%
43NAMS Newamsterdam Pharma Company44,359—$150万0.2%
44VSTM Verastem Inc309,685+25.8%$118万0.2%
45MDGL Madrigal Pharmaceuticals Inc1,787+0.0%$96万0.1%
46URGN Urogen Pharma Ltd24,500+0.0%$90万0.1%
47BCYC Bicycle Therapeutics Plc201,890+0.0%$86万0.1%
48XERS Xeris Biopharma Holdings Inc104,410+0.0%$83万0.1%
49ABEO Abeona Therapeutics Inc108,865+0.0%$67万0.1%
50INSP Inspire Med Sys Inc8,772+0.0%$39万0.1%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。